Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 89Leukemia 68Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma 26Leukemia, Erythroblastic, Acute 19Leukemia, Myelomonocytic, Acute 18Leukemia, Monocytic, Acute 18Leukemia, Megakaryoblastic, Acute 18Congenital Abnormalities 13Burkitt Lymphoma 13Lymphoma, Large B-Cell, Diffuse 12Myelodysplastic Syndromes 10Lymphoma, Non-Hodgkin 10Anemia, Refractory, with Excess of Blasts 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma, Follicular 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Eosinophilic, Acute 6Recurrence 5Myeloproliferative Disorders 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Promyelocytic, Acute 5Leukemia, Biphenotypic, Acute 5Leukemia, Basophilic, Acute 5Hodgkin Disease 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Myelodysplastic-Myeloproliferative Diseases 4Multiple Myeloma 4

Interventions

Radiotherapy 3Pyridoxine 2Etoposide 2Epoetin Alfa 2Cisplatin 2Capecitabine 2uridine triacetate 1peginterferon alfa-2b 1pegaspargase 1Vincristine 1Pyridostigmine Bromide 1Prednisolone 1Paclitaxel 1Oxaliplatin 1Octreotide 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Laparoscopy 1Introns 1Hydrocortisone 1Gemcitabine 1Furosemide 1Fluorouracil 1Filgrastim 1Erythropoietin 1Duloxetine Hydrochloride 1Doxorubicin 1Dexrazoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Drug-Related Side Effects and Adverse Reactions × Cytarabine × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡